Grimes & Company’s Ironwood Pharmaceuticals IRWD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.4K | Hold |
40,994
| – | – | ﹤0.01% | 412 |
|
|
2025
Q1 | $60.3K | Sell |
40,994
-1,681
| -4% | -$2.47K | ﹤0.01% | 363 |
|
|
2024
Q4 | $189K | Hold |
42,675
| – | – | 0.01% | 372 |
|
|
2024
Q3 | $176K | Hold |
42,675
| – | – | ﹤0.01% | 354 |
|
|
2024
Q2 | $278K | Buy |
42,675
+4,916
| +13% | +$32.1K | 0.01% | 277 |
|
|
2024
Q1 | $329K | Sell |
37,759
-1,381
| -4% | -$12K | 0.01% | 262 |
|
|
2023
Q4 | $448K | Sell |
39,140
-911
| -2% | -$10.4K | 0.01% | 228 |
|
|
2023
Q3 | $386K | Hold |
40,051
| – | – | 0.01% | 222 |
|
|
2023
Q2 | $426K | Hold |
40,051
| – | – | 0.02% | 218 |
|
|
2023
Q1 | $421K | Sell |
40,051
-7,795
| -16% | -$82K | 0.02% | 214 |
|
|
2022
Q4 | $593K | Hold |
47,846
| – | – | 0.03% | 189 |
|
|
2022
Q3 | $496K | Buy |
47,846
+1,155
| +2% | +$12K | 0.03% | 183 |
|
|
2022
Q2 | $538K | Sell |
46,691
-6,125
| -12% | -$70.6K | 0.03% | 186 |
|
|
2022
Q1 | $664K | Buy |
52,816
+4,684
| +10% | +$58.9K | 0.03% | 182 |
|
|
2021
Q4 | $561K | Buy |
48,132
+12
| +0% | +$140 | 0.03% | 192 |
|
|
2021
Q3 | $628K | Buy |
48,120
+2,922
| +6% | +$38.1K | 0.03% | 187 |
|
|
2021
Q2 | $582K | Buy |
45,198
+4,697
| +12% | +$60.5K | 0.03% | 189 |
|
|
2021
Q1 | $453K | Buy |
40,501
+26,494
| +189% | +$296K | 0.02% | 196 |
|
|
2020
Q4 | $160K | Hold |
14,007
| – | – | 0.01% | 257 |
|
|
2020
Q3 | $126K | Buy |
14,007
+2,622
| +23% | +$23.6K | 0.01% | 239 |
|
|
2020
Q2 | $117K | Sell |
11,385
-5,715
| -33% | -$58.7K | 0.01% | 237 |
|
|
2020
Q1 | $173K | Hold |
17,100
| – | – | 0.02% | 212 |
|
|
2019
Q4 | $228K | Hold |
17,100
| – | – | 0.01% | 240 |
|
|
2019
Q3 | $147K | Buy |
+17,100
| New | +$147K | 0.01% | 249 |
|